Multimodal Pain Management in Canine Cancer Care

Multimodal pain management combines approaches that act at different points in the pain pathway and addresses both the tumor and its functional consequences. A plan may include prescriptions, radiation, surgery, procedures, rehabilitation, nursing changes, and environmental support.

It is a strategy rather than a single drug. The veterinarian identifies likely inflammatory, neuropathic, visceral, bone, procedural, or mixed pain, checks comorbidities and interactions, then defines measurable comfort and function goals.

Pain management can begin at diagnosis and continue alongside tumor-directed treatment or hospice. It supports sleep, mobility, appetite, toileting, social interaction, and tolerance of procedures.

Combining lower-intensity approaches may improve comfort when one medicine is insufficient or poorly tolerated. Palliative radiation, nerve blocks, bisphosphonates, mobility aids, or rehabilitation may be relevant in selected cases.

Used for bone pain, surgical pain, neuropathic pain, oral or visceral discomfort, treatment effects, and end-of-life care. Frequent reassessment is essential because disease, organ function, and activity change.

AAHA pain and oncology guidance supports structured assessment, individualized multimodal plans, and routine reassessment. Evidence and suitability vary for each component and tumor type.

Sedation, GI injury, kidney or liver effects, bleeding, constipation, falls, and drug interactions depend on the medicines and patient. Human pain relievers can be toxic to dogs.

Do not combine NSAIDs, steroids, sedatives, cannabinoids, herbs, or supplements without veterinarian review. Pain behavior improving does not prove the tumor is controlled.